Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Schulz FI"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Montoro MJ; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Palomo L; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Acha P; MDS Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Badalona, Spain., Chan O; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Navarro V; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Kubota Y; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Schulz FI; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, University Hospital of Düsseldorf, Düsseldorf, Germany., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Briski R; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Al Ali N; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Xicoy B; MDS Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Badalona, Spain., López-Cadenas F; Department of Hematology, Hospital del Mar, Barcelona, Spain., Bosch F; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Barcelona, Spain., González T; Department of Hematology, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Eder LN; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Georg August University, Göttingen, Germany., Jerez A; Department of Hematology, Hospital Morales Meseguer, Murcia, Spain., Wang YH; Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, United Kingdom., Campagna A; Department of Biomedical Sciences, Humanitas Clinical and Research Center-IRCCS and Humanitas University, Milan, Italy., Santini V; Hematology, MDS Unit, University of Florence, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Bernal Del Castillo T; Department of Hematology, Servicio de Hematología, Hospital Universitario Central de Asturias Instituto de Investigación del Principado de Asturias, Oviedo, Spain., Such E; Department of Hematology, Servicio de Hematología, Hospital La Fe, Valencia, Spain., Tien HF; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Diaz Varela N; Department of Hematology, Servicio de Hematología, Hospital Universitario Central de Asturias Instituto de Investigación del Principado de Asturias, Oviedo, Spain., Platzbecker U; Department of Hematology, University Hospital of Leipzig, Dresden, Germany., Haase D; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Georg August University, Göttingen, Germany., Díez-Campelo M; Department of Hematology, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Della Porta M; Department of Biomedical Sciences, Humanitas Clinical and Research Center-IRCCS and Humanitas University, Milan, Italy., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Wiseman DH; Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, United Kingdom., Germing U; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, University Hospital of Düsseldorf, Düsseldorf, Germany., Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Sole F; MDS Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Badalona, Spain., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Valcárcel D; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Publikováno v:
Blood [Blood] 2024 Oct 17; Vol. 144 (16), pp. 1722-1731.
Autor:
Castaño-Díez S; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., López-Guerra M; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Zugasti I; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Calvo X; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Schulz FI; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Avendaño A; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Mora E; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Falantes-González JF; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Azaceta G; Grupo Español de Síndromes mielodisplásicos (GESMD), Spain., Ibañez M; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Chen-Liang TH; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Notario Mc Donnell C; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Amer-Salas N; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain., Palomo L; Institut Catala d'Oncololgia, Badalona, Spain., Pomares H; Institut Català d'Oncologia, BARCELONA, Spain., Vila J; Institut Català d'Oncologia (ICO) - Hospital Dr. Josep Trueta, Girona, Spain., Girona, Spain., Bernal Del Castillo T; Hospital Central de Asturia, ISPA, IUOPAs, Oviedo, Spain., Jiménez-Vicente C; Hospital Clínic de Barcelona, Barcelona, Spain., Esteban D; Institut Català d'Oncologia-Hospital Germans Trias i Pujol. Josep Carreras Research Institute. Badalona. Universitat Autònoma de Barcelona, Badalona, Spain., Guijarro F; Hospital Clinic de Barcelona, Barcelona, Spain., Álamo Moreno JR; Hospital Clinic of Barcelona, Barcelona, Spain., Cortés-Bullich A; Hospital Clinic de Barcelona, Barcelona, Spain., Torrecillas-Mayayo V; University of Barcelona, Barcelona, Spain., Triguero A; Hematology Department, Hospital Clínic, Barcelona, Spain., Mont-de Torres L; University of Barcelona, Barcelona, Spain., Carcelero E; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Cardús A; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Germing U; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Betz B; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Rozman M; Institut de Recerca contra la Leucèmia Josep Carreras, Badalona; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Arenillas L; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Zamora L; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Díez-Campelo M; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Xicoy B; Institut de Recerca contra la Leucèmia Josep Carreras, Badalona; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain., Esteve J; IDIBAPS, Hospital Clinic, Barcelona, Spain., Díaz-Beyá M; Grupo Español de Síndromes Mielodisplásicos (GESMD), Spain.
Publikováno v:
Blood advances [Blood Adv] 2024 Oct 10. Date of Electronic Publication: 2024 Oct 10.
Autor:
Cacic AM; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine Universität Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany., Schulz FI; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine Universität Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany., Germing U; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine Universität Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany., Dietrich S; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine Universität Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany., Gattermann N; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine Universität Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Dec 15; Vol. 13, pp. 1303785. Date of Electronic Publication: 2023 Dec 15 (Print Publication: 2023).